For fem ud af de 36 positive udtalelser, CPMP vedtog i 2000, var der forudgående ydet videnskabelig rådgivning.
Work continued on the development of EudraVigilance, the electronic Community pharmacovigilance system for transmission and management of adverse drug reactions.